Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 1,590 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Activity Monitoring Clear all

Conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
Interventions: Conditioning Regimen A, Conditioning Regimen B, Conditioning Regimen C, Conditioning Regimen D, Conditioning Regimen E, Hematopoietic Cell Transplantation, PTCy (50 mg/kg D3, D4), PTCy (25 mg/kg D3, D4), Post-transplant Tacrolimus, Post-transplant Mycophenolate mofetil, Post-transplant Abatacept, Post-transplant Ruxolitinib, Supportive Care: Growth Factors, Supportive Care: Blood Products, Supportive Care: Infection Prophylaxis, Supportive Care: Intravenous immune globulin (IVIG), Supportive Care: Seizure prophylaxis, Supportive Care: Monitoring and management of CRS, Supportive Care: Prophylaxis against infections, Supportive Care: Prophylaxis against infections, Supportive Care: Lipid elevations, Study treatment compliance, Prohibited Concomitant Therapy, Permitted Concomitant Therapy; Drug · Procedure · Other
Lead sponsor: Center for International Blood and Marrow Transplant Research; Network
Eligibility: 18 Years to 66 Years
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 13
States / cities: Birmingham, Alabama • Duarte, California • Palo Alto, California + 10 more

Conditions: Obesity, Weight Loss
Interventions: Component 1: Calorie Goal Attainment, Component 2: Diet Quality, Component 3: Physical Activity Goal Attainment, Component 4: Goal Setting; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Familial Hypercholesterolemia
Interventions: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, Implementation strategy package: Stage implementation scale up; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 26 Years and older
Enrollment: 532 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Multiple Locations, Pennsylvania

Conditions: Parkinson's Disease (PD), Alzheimer's Disease (AD) and Related Disorders, Older Adults (60 - 85 Years Old)
Interventions: Complex Rhythmic Movement Sequences (CRMS) Sessions; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chronic Pain
Interventions: Sham Phoenix Laser Treatment, Active Phoenix Laser Treatment; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pancreatic Cancer
Interventions: Physical Activity, Nutrition Counseling, Resistance Training; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: DCIS, Ductal Carcinoma in Situ
Interventions: Surgery, Active Monitoring; Other
Lead sponsor: Alliance Foundation Trials, LLC.; Other
Eligibility: 40 Years to 99 Years · Female only
Enrollment: 997 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 141
States / cities: Anchorage, Alaska • Phoenix, Arizona • Duarte, California + 117 more

Conditions: Asthma
Interventions: PLASMA; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 12 Years to 20 Years
Enrollment: 371 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 4
States / cities: Baltimore, Maryland • Buffalo, New York • Rochester, New York + 1 more

Conditions: Obsessive-Compulsive Disorder
Interventions: Stereoencephalography (SEEG), Deep Brain Stimulation (DBS); Device
Lead sponsor: Casey H. Halpern, M.D.; Other
Eligibility: 22 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 2
States / cities: Stanford, California • Philadelphia, Pennsylvania

Conditions: Vocal Cord Dysfunction
Interventions: Four therapy sessions with a psychologist utilizing cognitive-behavioral therapy techniques, Cognitive Behavioral Therapy (CBT); Behavioral
Lead sponsor: CAMC Health System; Other
Eligibility: 13 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Hypertension
Interventions: Core intervention (Fitbit tracking and BP health education), Aerobic training (AT), Dynamic resistance training (DRT), Isometric resistance training (IRT); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 44 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sepsis, Septic Shock, Emergencies
Interventions: Septic Shock Clinical Decision Support, Clinical Diagnosis Only; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 1,345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Type2 Diabetes
Interventions: Phone-Based Health Coaching Utilizing Lifestyle Action Plans; Behavioral
Lead sponsor: Beacon Health System; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: South Bend, Indiana

Conditions: CHF, Congestive Heart Failure
Interventions: Data collection; Other
Lead sponsor: Sensorum Health Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Pediatric Obesity
Interventions: Comprehensive behavioral weight control program, Individual 12-month nutrition education program; Behavioral · Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 10 Years to 14 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity & Overweight, Breast Cancer
Interventions: THRIVE NOW; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Depression, Stress, Sleep, Anxiety
Interventions: Moodlifters, Physical Activity, Nature Experiences; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 25 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Obesity, Childhood
Interventions: Regulation of Cues +, Family Based Behavioral Treatment, Health Education; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 7 Years to 12 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: La Jolla, California • Minneapolis, Minnesota

Conditions: Ductal Carcinoma in Situ
Interventions: Decision Support Tool with Active Monitoring, Decision Support Tool without Active Monitoring; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 50 Years to 79 Years · Female only
Enrollment: 322 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Alcohol Dependence
Interventions: Telephone Monitoring and Feedback, Telephone Monitoring and Counseling; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 252 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bronchopulmonary Dysplasia
Interventions: Minimally invasive surfactant therapy, Continuation on CPAP; Device · Other
Lead sponsor: Menzies Institute for Medical Research; Other
Eligibility: 1 Minute to 6 Hours
Enrollment: 486 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 5
States / cities: New Haven, Connecticut • Honolulu, Hawaii • Evanston, Illinois + 2 more

Conditions: Physical Activity, Cancer of the Prostate, Cognitive Impairment, Quality of Life
Interventions: Supervised Physical Activity Plus Behavioral Counseling, Supervised Physical Activity Plus Exercise Counseling; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Glioma
Interventions: Biospecimen Collection, Dasatinib, Fisetin, Magnetic Resonance Imaging, Patient Observation, Positron Emission Tomography, Quercetin, Temozolomide, Topoisomerase-1 Inhibitor LMP744, Single Agent Therapy; Procedure · Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Weight Loss, Diet Modification, Aging, Weight Change, Body, Dietary Habits
Interventions: Weight loss intervention months 0-6, Exercise intervention months 0-6, Carbohydrate supplement for months 0-6, Protein supplement for months 0-6, Protein supplement for follow-up months 7-18; Behavioral · Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 85 Years
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Optimizing Self-Monitoring Feedback for the Treatment of Obesity

Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)

Moving Yourself in Space and Time: MYSTIC

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

Peer Led Asthma Self Management for Adolescents: PLASMA

SEEG-Guided DBS for OCD

A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study

A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control

Implementation Trial of Predictive Modeling to Enhance Diagnosis and Improve Treatment in Pediatric Septic Shock

Pilot of Virtual Health Coaching Utilizing Lifestyle for Under-Resourced Patients With Type II Diabetes

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF

Bone Health of Obese Adolescents During Weight Loss

Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer Care

The Lived Experiences Measured Using Rings Pilot Study

Family, Responsibility, Education, Support, and Health for Food Responsiveness

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

Effectiveness of Extended Telephone Monitoring

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Prostate Cancer Survivors and Exercise and Behavioral Counseling

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Utilizing Protein During Weight Loss to Impact Physical Function